SINGAPORE (Reuters) – China announced on Friday that it will require export permits for certain graphite products to protect national security, its…
Is It Too Late to Buy Solana? SOL Price Climbs 17% as Interest in New Crypto Casino Grows – What Does it Do?
By Press Room
4 Mins read
Solana (SOL) has climbed an impressive +17% overnight in a strong bounce off 20DMA support, but with SOL trading high – is…
© Reuters. Toronto-Dominion Bank (TSX:TD) and Canadian National Railway (TSX:) have continued to offer stability and dividends, attracting investors seeking consistent returns…
Vietnam arrests rare earth industry officials, casting shadow over plans to rival China
By Press Room
2 Mins read
By Khanh Vu and Francesco Guarascio HANOI (Reuters) -Police in Vietnam have arrested six people accused of violating mining regulations, including the…
Security Concerns Prompt Bitcoin Core Developer to Leave Lightning Network
By Press Room
2 Mins read
Antoine Riard, a security researcher and developer, has announced his departure from the Lightning Network’s development team, citing security issues and challenges…
Stock-market investors face reality of 5% Treasury yields. Here’s what’s next.
By Press Room
3 Mins read
The rising yields on U.S. government debt, which sent the 10-year Treasury rate near 5%, a level not seen in 16 years,…
TSMC Arizona chip factory launch delayed to 2025, cites workforce shortage
By Press Room
2 Mins read
© Reuters. Taiwan Semiconductor Manufacturing Co. (TSMC), a prominent player in the Semiconductors & Semiconductor Equipment industry, has announced a delay in…
SINGAPORE/LONDON (Reuters) – China will require export permits for some graphite products to protect national security, its commerce ministry said on Friday,…
EBA and ESMA Release Consultation Paper on Assessing Suitability for Crypto-Asset Service Providers
By Press Room
2 Mins read
The European Banking Authority (EBA) and the European Securities and Markets Authority (ESMA) published a joint consultation paper on two draft guidelines….
Alectinib shows promise in phase 3 ALINA trial for non-small cell lung cancer
By Press Room
2 Mins read
© Reuters. The 2023 ESMO Congress showcased the results of the phase 3 ALINA trial, revealing that alectinib, an oral ALK inhibitor,…